Predictive and prognostic value of FDG-PET/CT imaging and different response evaluation criteria after primary systemic therapy of breast cancer

被引：0
|
作者：
Tímea Tőkés
Kornélia Kajáry
Gyöngyvér Szentmártoni
Zsolt Lengyel
Tamás Györke
László Torgyík
Krisztián Somlai
Anna-Mária Tőkés
Janina Kulka
Magdolna Dank
机构：
[1] Semmelweis University,Oncological Division, 1st Department of Internal Medicine
[2] Pozitron PET/CT Center,Department of Nuclear Medicine
[3] Semmelweis University,MTA
[4] Scanomed Ltd,SE Tumor Progression Research Group
[5] Surgical Division of the St Margaret Hospital,2nd Department of Pathology
[6] 2nd Department of Pathology,undefined
[7] Semmelweis University,undefined
来源：
Breast Cancer | 2017年 / 24卷
关键词：
Breast cancer; Primary systemic therapy; FDG-PET/CT; PERCIST; RECIST;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：137 / 146
页数：9
相关论文
共 50 条
  • [31] Prognostic value of tumor heterogeneity evaluated by FDG-PET/CT imaging in lung cancer patients.
    Hughes, Nicola Marie
    Mou, Tian
    O'Regan, Kevin N.
    Murphy, Peter
    O'Sullivan, Janet N.
    Wolsztynski, Eric
    Huang, Jian
    Kennedy, Marcus
    Eary, Janet F.
    O'Sullivan, Finbarr
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [32] Prognostic value of FLT-PET/CT in patients with pancreatic cancer: comparison with FDG-PET/CT
    Nakajo, Masatoyo
    Kajiya, Yoriko
    Tani, Atsushi
    Jinguji, Megumi
    Nakajo, Masayuki
    Fukukura, Yoshihiko
    Yoshiura, Takashi
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [33] Value of FDG-PET/CT Volumetry After Chemoradiotherapy in Rectal Cancer
    Okuno, Takayuki
    Kawai, Kazushige
    Koyama, Keitaro
    Takahashi, Miwako
    Ishihara, Soichiro
    Momose, Toshimitsu
    Morikawa, Teppei
    Fukayama, Masashi
    Watanabe, Toshiaki
    DISEASES OF THE COLON & RECTUM, 2018, 61 (03) : 320 - 327
  • [34] Utility of FDG-PET in the evaluation of recurrence breast cancer. A comparison with CT imaging.
    Benitez, A.
    Albala, M. D.
    Maza, R.
    Contreras, P. I.
    Pacheco, C.
    Latre, J. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S417 - S417
  • [35] FDG-PET/CT for systemic staging of patients with newly diagnosed breast cancer
    Groheux, David
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) : 1417 - 1419
  • [36] FDG-PET/CT for systemic staging of patients with newly diagnosed breast cancer
    David Groheux
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1417 - 1419
  • [37] Comparison of EORTC criteria and PERCIST for FDG PET/CT response evaluation of patients with metastatic breast cancer treated with a first line of systemic therapy
    Depardon, E.
    Kanoun, S.
    Humbert, O.
    Riedinger, J.
    Lasserre, M.
    Toubeau, M.
    Berriolo-Riedinger, A.
    Dygai-Cochet, I.
    Fumoleau, P.
    Brunotte, F.
    Cochet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S266 - S266
  • [38] FDG-PET/CT imaging to monitor the response of esophagus cancer to proton-beam therapy
    Nakagami, Y.
    Kobayashi, T.
    Ogawa, T.
    Hara, T.
    Satake, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S363 - S363
  • [39] Evaluation of the Usefulness of FDG-PET/CT for Nodal Staging of Breast Cancer
    Orsaria, Paolo
    Chiaravalloti, Agostino
    Caredda, Emanuele
    Marchese, Paola Valeria
    Titka, Brisida
    Anemona, Lucia
    Portarena, Ilaria
    Schillaci, Orazio
    Petrella, Giuseppe
    Palombi, Leonardo
    Buonomo, Oreste Claudio
    ANTICANCER RESEARCH, 2018, 38 (12) : 6639 - 6652
  • [40] The added value of metabolic imaging with FDG-PET in oesophageal cancer: prognostic role and prediction of response to treatment
    Emilio Bombardieri
    European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 753 - 758
12345